Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiocarcinoma | 4 | 2020 | 12 | 2.120 |
Why?
|
| Bile Duct Neoplasms | 3 | 2019 | 12 | 1.940 |
Why?
|
| Cilia | 4 | 2020 | 6 | 1.200 |
Why?
|
| Histone Deacetylase 6 | 3 | 2020 | 3 | 1.000 |
Why?
|
| Chemoreceptor Cells | 1 | 2019 | 1 | 0.690 |
Why?
|
| MicroRNAs | 1 | 2018 | 42 | 0.630 |
Why?
|
| Ciliopathies | 1 | 2017 | 1 | 0.620 |
Why?
|
| Bile Ducts | 1 | 2017 | 12 | 0.610 |
Why?
|
| Epithelial Cells | 1 | 2017 | 88 | 0.580 |
Why?
|
| Prostatic Neoplasms | 3 | 2020 | 106 | 0.510 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 265 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 100 | 0.240 |
Why?
|
| Cell Proliferation | 2 | 2020 | 202 | 0.200 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2020 | 1 | 0.190 |
Why?
|
| Immunomodulation | 1 | 2020 | 8 | 0.190 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2020 | 4 | 0.190 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 18 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 34 | 0.190 |
Why?
|
| Rats | 2 | 2020 | 859 | 0.180 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2019 | 3 | 0.180 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 3 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 21 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 173 | 0.170 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2019 | 2 | 0.170 |
Why?
|
| Adenylyl Cyclases | 1 | 2019 | 10 | 0.170 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 10 | 0.170 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 28 | 0.170 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 41 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 76 | 0.170 |
Why?
|
| Cell Movement | 1 | 2019 | 105 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 56 | 0.160 |
Why?
|
| Karyopherins | 1 | 2018 | 1 | 0.160 |
Why?
|
| Animals | 4 | 2020 | 4580 | 0.160 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 29 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 47 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 78 | 0.160 |
Why?
|
| Humans | 9 | 2020 | 29363 | 0.160 |
Why?
|
| Blotting, Western | 1 | 2018 | 170 | 0.160 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 3 | 0.150 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2017 | 9 | 0.150 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 1 | 0.140 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 3 | 0.140 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 10 | 0.140 |
Why?
|
| Apoptosis | 1 | 2017 | 251 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 218 | 0.130 |
Why?
|
| Genes, Modifier | 1 | 2014 | 1 | 0.130 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2014 | 2 | 0.130 |
Why?
|
| beta-Thalassemia | 1 | 2014 | 3 | 0.130 |
Why?
|
| Frameshift Mutation | 1 | 2014 | 5 | 0.130 |
Why?
|
| beta-Globins | 1 | 2014 | 4 | 0.130 |
Why?
|
| Phenotype | 1 | 2016 | 357 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2017 | 483 | 0.130 |
Why?
|
| Family | 1 | 2014 | 88 | 0.120 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 101 | 0.090 |
Why?
|
| Male | 6 | 2020 | 15640 | 0.080 |
Why?
|
| Mice | 2 | 2020 | 1620 | 0.060 |
Why?
|
| Liquid Biopsy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 35 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2020 | 12 | 0.050 |
Why?
|
| Zebrafish | 1 | 2020 | 21 | 0.050 |
Why?
|
| Prostatectomy | 1 | 2020 | 18 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2020 | 5 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2020 | 21 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 80 | 0.050 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 9 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 55 | 0.050 |
Why?
|
| Autophagy | 1 | 2020 | 30 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2020 | 70 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 23 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 89 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2020 | 3476 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2020 | 124 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 391 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 108 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 175 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 220 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 298 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 348 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 840 | 0.040 |
Why?
|
| Chromosome Banding | 1 | 2016 | 3 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2016 | 8 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 59 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 45 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2016 | 81 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 76 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 91 | 0.030 |
Why?
|
| Argentina | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 277 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 531 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 788 | 0.030 |
Why?
|
| Female | 2 | 2016 | 16214 | 0.020 |
Why?
|
| Adult | 1 | 2014 | 8606 | 0.010 |
Why?
|